SCHEMBL13656002

SCHEMBL13656002

Cc1sc(C)c(Cc2ccc(Cl)cc2)c1C=O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGER4 P35408 1/20 0.45
PTGER2 P43116 1/20 0.45
VDR P11473 1/20 0.41
ALDH1A1 P00352 1/20 0.39
PTGS1 P23219 1/20 0.39
PTGS2 P35354 1/20 0.39
LMNA P02545 1/20 0.38
MAPT P10636 1/20 0.38
HTT P42858 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
SLC6A2 P23975 2/20 0.38
SLC6A3 Q01959 2/20 0.38
HTR2A P28223 1/20 0.38
SLC6A4 P31645 1/20 0.38
HRH1 P35367 1/20 0.38
HTR2B P41595 1/20 0.38
CHRNA4 P43681 1/20 0.38
ENPP2 Q13822 1/20 0.36
KMT2A Q03164 2/20 0.36
MEN1 O00255 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13655991 0.83 PTGER4 (0.48) PTGER4PTGER2ALDH1A1LMNAKMT2A
SCHEMBL13229813 0.80 PTGER4 (0.48) PTGER4PTGER2ALDH1A1KMT2AGAA
SCHEMBL18647553 0.71 ALDH1A1 (0.44) PTGER4PTGER2ALDH1A1PTGS1PTGS2
SCHEMBL13655838 0.71 PTGER4 (0.51) PTGER4PTGER2HTR2AHTR2BAR
SCHEMBL9192605 0.69 KMT2A (0.47) PTGS1PTGS2LMNAMAPTSLC6A2
SCHEMBL12123971 0.65 MEN1 (0.32) ALDH1A1KMT2AMEN1
SCHEMBL3985532 0.65 HSP90AB1 (0.43) ALDH1A1PTGS1PTGS2MAPTNPSR1
SCHEMBL1106684 0.63 IDO1 (0.58) ALDH1A1LMNAMAPTSLC6A2SLC6A3
SCHEMBL9185748 0.63 KMT2A (0.43) PTGS1PTGS2MAPTSLC6A2SLC6A3
SCHEMBL13230149 0.63 ALDH1A1 (0.41) ALDH1A1HTTKMT2AMEN1TAAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090247596-A1 THIOPHENECARBOXAMIDE DERIVATIVES AS EP4 RECEPTOR LIGANDS MERCK CANADA INC. (CA) 2009-10-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090247596-A1 THIOPHENECARBOXAMIDE DERIVATIVES AS EP4 RECEPTOR LIGANDS PTGER4, PTGER1, PTGER2 PTGER4 1/4885PTGER2 3/4885VDR 622/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.